Recent studies found that SLC7A11 is highly expressed in non-small cell lung cancer, oral cancer, prostate cancer, malignant glioma and other cancers, which is closely related to cancer proliferation, invasion, metastasis and drug resistance [85]. Here, SLC7A11 is linked to prostate cancer.